ATHERSYS, INC / NEW

2023 Q4 Form 10-Q Financial Statement

#000143774923032255 Filed on November 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.020M $13.78M
YoY Change -92.6% -72.25%
Cash & Equivalents $1.000M $13.80M
Short-Term Investments
Other Short-Term Assets $1.210M $6.306M
YoY Change -80.81% 205.23%
Inventory
Prepaid Expenses
Receivables $0.00 $660.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.230M $20.75M
YoY Change -89.25% -64.31%
LONG-TERM ASSETS
Property, Plant & Equipment $4.236M $5.438M
YoY Change -22.1% 50.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $940.0K $1.226M
YoY Change -23.33% -18.86%
Total Long-Term Assets $5.198M $14.80M
YoY Change -64.87% 6.04%
TOTAL ASSETS
Total Short-Term Assets $2.230M $20.75M
Total Long-Term Assets $5.198M $14.80M
Total Assets $7.428M $35.54M
YoY Change -79.1% -50.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.295M $29.18M
YoY Change -68.15% 70.85%
Accrued Expenses $10.53M $1.108M
YoY Change 850.36% 92.03%
Deferred Revenue $150.0K
YoY Change
Short-Term Debt $10.79M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $38.62M $38.73M
YoY Change -0.27% 39.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.200M $119.0K
YoY Change 4269.75% -99.21%
Total Long-Term Liabilities $5.200M $119.0K
YoY Change 4269.75% -99.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.62M $38.73M
Total Long-Term Liabilities $5.200M $119.0K
Total Liabilities $43.82M $38.85M
YoY Change 12.8% -9.11%
SHAREHOLDERS EQUITY
Retained Earnings -$680.4M -$642.9M
YoY Change 5.83% 14.47%
Common Stock $642.8M $626.3M
YoY Change 2.64% 5.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$36.40M -$16.61M
YoY Change
Total Liabilities & Shareholders Equity $7.428M $35.54M
YoY Change -79.1% -50.7%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001368148
dei Entity Registrant Name
EntityRegistrantName
ATHERSYS, INC / NEW
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26758431
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26758431
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17986147
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17986147
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33876
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4864095
dei Entity Address Address Line1
EntityAddressAddressLine1
3201 Carnegie Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Cleveland
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44115-2634
dei City Area Code
CityAreaCode
216
dei Local Phone Number
LocalPhoneNumber
431-9900
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61718815
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1020000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9038000 usd
CY2023Q3 athx Prepaid Clinical Trial Costs Current
PrepaidClinicalTrialCostsCurrent
0 usd
CY2022Q4 athx Prepaid Clinical Trial Costs Current
PrepaidClinicalTrialCostsCurrent
2747000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1210000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1034000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2230000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
13535000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7846000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4236000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4214000 usd
CY2023Q3 athx Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
936000 usd
CY2022Q4 athx Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
2136000 usd
CY2023Q3 us-gaap Assets
Assets
7428000 usd
CY2022Q4 us-gaap Assets
Assets
27731000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9295000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27765000 usd
CY2023Q3 athx Deferred Accounts Payable Current
DeferredAccountsPayableCurrent
7862000 usd
CY2022Q4 athx Deferred Accounts Payable Current
DeferredAccountsPayableCurrent
0 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7792000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
746000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
890000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1090000 usd
CY2023Q3 athx Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
360000 usd
CY2022Q4 athx Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
7231000 usd
CY2023Q3 athx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1490000 usd
CY2022Q4 athx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1078000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
10785000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
150000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
534000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
38624000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
38444000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7939000 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
27000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
18000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
642754000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
632009000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-680384000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-655878000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1208000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-36395000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-23851000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7428000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27731000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5294000 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
65000 usd
us-gaap Revenues
Revenues
49000 usd
us-gaap Revenues
Revenues
5294000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3995000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12424000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19111000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54162000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2808000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3737000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7968000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12999000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
977000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
617000 usd
us-gaap Depreciation
Depreciation
1072000 usd
us-gaap Depreciation
Depreciation
1482000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
7780000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
16778000 usd
us-gaap Costs And Expenses
CostsAndExpenses
28151000 usd
us-gaap Costs And Expenses
CostsAndExpenses
68643000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7780000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16713000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28102000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-63349000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4009000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3044000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3596000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3816000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3771000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13669000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24506000 usd
us-gaap Net Income Loss
NetIncomeLoss
-59533000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.58
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24492
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11855
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21184
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10676
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3771000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13669000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24506000 usd
us-gaap Net Income Loss
NetIncomeLoss
-59533000 usd
CY2023Q3 us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax Parent
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTaxParent
1208000 usd
CY2022Q3 us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax Parent
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTaxParent
0 usd
us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax Parent
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTaxParent
1208000 usd
us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax Parent
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTaxParent
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1208000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1208000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2563000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13669000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23298000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59533000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-23851000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
707000 usd
CY2023Q1 athx Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-56000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7811000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-31011000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
568000 usd
CY2023Q2 athx Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3338000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2685000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-75000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-12924000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-37419000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
646000 usd
CY2023Q3 athx Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2991000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1208000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-50000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3771000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-36395000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16369000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1410000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4803000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-58000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22216000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
308000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1945000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9698000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-40000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23648000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-11737000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2001000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4593000 usd
CY2022Q3 athx Shares Issued During Period Value Exercise Of Warrants
SharesIssuedDuringPeriodValueExerciseOfWarrants
2233000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-33000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13669000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-16612000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24506000 usd
us-gaap Net Income Loss
NetIncomeLoss
-59533000 usd
us-gaap Depreciation
Depreciation
1072000 usd
us-gaap Depreciation
Depreciation
1482000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2611000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
7746000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5435000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
664000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1921000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5356000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
568000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
athx Change In Fair Value Of Note Payables
ChangeInFairValueOfNotePayables
-3192000 usd
athx Change In Fair Value Of Note Payables
ChangeInFairValueOfNotePayables
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
11000 usd
athx Gain Loss On Abandonment Of Fixed Assets
GainLossOnAbandonmentOfFixedAssets
-427000 usd
athx Gain Loss On Abandonment Of Fixed Assets
GainLossOnAbandonmentOfFixedAssets
-0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2151000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2784000 usd
athx Issuance Costs Allocated To Warrant Liabilities
IssuanceCostsAllocatedToWarrantLiabilities
0 usd
athx Issuance Costs Allocated To Warrant Liabilities
IssuanceCostsAllocatedToWarrantLiabilities
560000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-52000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-3754000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
163000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1262000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1323000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4472000 usd
athx Increase Decrease In Accounts Payable Related To Collaborative Arrangements
IncreaseDecreaseInAccountsPayableRelatedToCollaborativeArrangements
0 usd
athx Increase Decrease In Accounts Payable Related To Collaborative Arrangements
IncreaseDecreaseInAccountsPayableRelatedToCollaborativeArrangements
-1119000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
150000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3340000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14398000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46990000 usd
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
227000 usd
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
41000 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
-0 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
2044000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
227000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2003000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14500000 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
6334000 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
10997000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
182000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
131000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6153000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25368000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8018000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23625000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9038000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37407000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1020000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13782000 usd
athx Issuance Of Warrants Noncash Activies
IssuanceOfWarrantsNoncashActivies
usd
athx Issuance Of Warrants Noncash Activies
IssuanceOfWarrantsNoncashActivies
413000 usd
athx Reclass Of Warrant Liability Upon Exercise Noncash Activity
ReclassOfWarrantLiabilityUponExerciseNoncashActivity
2685000 usd
athx Reclass Of Warrant Liability Upon Exercise Noncash Activity
ReclassOfWarrantLiabilityUponExerciseNoncashActivity
2231000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1000000 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58672949
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5303238
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58672949
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5703238
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14600000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13823000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10364000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9609000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4236000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4214000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
7200000 usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
1000000 usd
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
400000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
300000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-300000 usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 usd
CY2023Q3 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
900000 usd
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
400000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
7900000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3200000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 athx Issuance Costs Allocated To Warrant Liabilities
IssuanceCostsAllocatedToWarrantLiabilities
500000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
400000 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2611000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 athx Change In Fair Value Of Note Payables
ChangeInFairValueOfNotePayables
-3832000 usd
CY2022Q3 athx Change In Fair Value Of Note Payables
ChangeInFairValueOfNotePayables
-0 usd
athx Change In Fair Value Of Note Payables
ChangeInFairValueOfNotePayables
-3192000 usd
athx Change In Fair Value Of Note Payables
ChangeInFairValueOfNotePayables
-0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
211000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
-44000 usd
us-gaap Interest Expense
InterestExpense
545000 usd
us-gaap Interest Expense
InterestExpense
-31000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
287000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
631000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
109000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
915000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2784000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2151000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2784000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-467000 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
11000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-321000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
11000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
568000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-426000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
701000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4009000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3044000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3596000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3816000 usd
CY2023Q2 athx Forbearance Agreement Deferred Accounts Payable
ForbearanceAgreementDeferredAccountsPayable
11800000 usd
CY2023Q2 athx Forbearance Agreement Deferred Accounts Payable Monthly Payments
ForbearanceAgreementDeferredAccountsPayableMonthlyPayments
250000 usd
CY2023Q2 athx Deferred Accounts Payable Fair Value
DeferredAccountsPayableFairValue
7900000 usd
CY2023Q2 athx Forbearance Agreement Deferred Accounts Payable Payment Term
ForbearanceAgreementDeferredAccountsPayablePaymentTerm
P48M
CY2023Q2 athx Forbearance Agreement Deferred Accounts Payable
ForbearanceAgreementDeferredAccountsPayable
11800000 usd
CY2023Q2 athx Forbearance Agreement Deferred Accounts Payable Cash Payment Not Paid When Due Subject To Interest Rate
ForbearanceAgreementDeferredAccountsPayableCashPaymentNotPaidWhenDueSubjectToInterestRate
0.10 pure
CY2023Q2 athx Forbearance Agreement Deferred Accounts Payable Cash Payment Due Benchmark Period
ForbearanceAgreementDeferredAccountsPayableCashPaymentDueBenchmarkPeriod
P60D
CY2022Q2 athx Restructuring And Related Cost Reduction In Workforce Percentage
RestructuringAndRelatedCostReductionInWorkforcePercentage
0.70 pure
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
985000 usd
us-gaap Restructuring Charges
RestructuringCharges
61000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
701000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
345000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
341000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
30000 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
26000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
345000 usd
CY2023Q3 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
0 usd

Files In Submission

Name View Source Status
0001437749-23-032255-index-headers.html Edgar Link pending
0001437749-23-032255-index.html Edgar Link pending
0001437749-23-032255.txt Edgar Link pending
0001437749-23-032255-xbrl.zip Edgar Link pending
athx-20230930.xsd Edgar Link pending
athx20230930_10q.htm Edgar Link pending
ex_567099.htm Edgar Link pending
ex_567100.htm Edgar Link pending
ex_567101.htm Edgar Link pending
ex_591110.htm Edgar Link pending
ex_591111.htm Edgar Link pending
ex_591112.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
athx-20230930_pre.xml Edgar Link unprocessable
athx-20230930_cal.xml Edgar Link unprocessable
athx-20230930_lab.xml Edgar Link unprocessable
athx-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
athx20230930_10q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending